Revilleza, Isabelita C.

HRN: 28-18-27  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/22/2025
AZITHROMYCIN 500MG TABLET (TAB)
12/22/2025
03/22/2026
PO
500mg
3x/week MWF
HIV Prophylaxis
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: